• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔内压力气溶胶化疗(PIPAC):职业健康与安全方面。

Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects.

机构信息

Department of Pathology, Ruhr University Bochum, Bochum, Germany.

出版信息

Ann Surg Oncol. 2013 Oct;20(11):3504-11. doi: 10.1245/s10434-013-3039-x. Epub 2013 Jun 14.

DOI:10.1245/s10434-013-3039-x
PMID:23765417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3764316/
Abstract

BACKGROUND

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel approach for treating peritoneal carcinomatosis. First encouraging results have been obtained in human patients. However, delivering chemotherapy as an aerosol might result in an increased risk of exposure to health care workers, as compared with other administration routes.

METHODS

PIPAC was applied in two human patients using chemotherapeutic drugs (doxorubicin and cisplatin), and air contamination levels were measured under real clinical conditions. Air was collected on a cellulose nitrate filter with a flow of 22.5 m(3)/h. To exclude any risk for health care workers, both procedures were remote controlled. Toxicological research of cisplatin was performed according to NIOSH 7300 protocol. Sampling and analysis were performed by an independent certification organization.

RESULTS

The following safety measures were implemented: closed abdomen, laminar airflow, controlled aerosol waste, and protection curtain. No cisplatin was detected in the air (detection limit < 0.000009 mg/m(3)) at the working positions of the surgeon and the anesthesiologist under real PIPAC conditions.

CONCLUSIONS

For the drugs tested, PIPAC is in compliance with European Community working safety law and regulations. Workplace contamination remains below the tolerance margin. The safety measures and conditions as defined above are sufficient. Further protecting devices, such as particulate (air purifying) masks, are not necessary. PIPAC can be used safely in the clinical setting if the conditions specified above are met. However, a toxicological workplace analysis must be performed to confirm that the procedure as implemented complies with local regulations.

摘要

背景

加压腹腔内气溶胶化疗(PIPAC)是一种治疗腹膜癌病的新方法。在人体患者中已获得了初步令人鼓舞的结果。然而,与其他给药途径相比,将化疗作为气溶胶给药可能会增加医护人员接触的风险。

方法

在两名人类患者中应用 PIPAC,并在真实临床条件下测量空气污染物水平。使用流量为 22.5 m³/h 的硝酸纤维素滤器收集空气。为了排除对医护人员的任何风险,两个程序均采用遥控操作。根据 NIOSH 7300 协议对顺铂进行毒理学研究。采样和分析由独立认证机构进行。

结果

实施了以下安全措施:封闭腹部、层流空气、控制气溶胶废物和保护幕。在真实的 PIPAC 条件下,手术医生和麻醉师的工作位置未检测到空气中的顺铂(检测限<0.000009 mg/m³)。

结论

对于测试的药物,PIPAC 符合欧洲共同体工作安全法和法规。工作场所污染仍低于容忍限度。上述定义的安全措施和条件是足够的。不需要进一步的保护设备,如颗粒(空气净化)口罩。如果满足上述规定,则可以在临床环境中安全使用 PIPAC。但是,必须进行毒理学工作场所分析以确认所实施的程序符合当地法规。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae9/3764316/e4bc5c86b3bd/10434_2013_3039_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae9/3764316/bc8be7ae3331/10434_2013_3039_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae9/3764316/3308eaec4875/10434_2013_3039_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae9/3764316/e4bc5c86b3bd/10434_2013_3039_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae9/3764316/bc8be7ae3331/10434_2013_3039_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae9/3764316/3308eaec4875/10434_2013_3039_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bae9/3764316/e4bc5c86b3bd/10434_2013_3039_Fig3_HTML.jpg

相似文献

1
Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects.腹腔内压力气溶胶化疗(PIPAC):职业健康与安全方面。
Ann Surg Oncol. 2013 Oct;20(11):3504-11. doi: 10.1245/s10434-013-3039-x. Epub 2013 Jun 14.
2
Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow.在没有层流气流的手术室中进行加压腹腔内气溶胶化疗(PIPAC)的职业安全。
J Visc Surg. 2019 Dec;156(6):485-488. doi: 10.1016/j.jviscsurg.2019.06.010. Epub 2019 Jul 8.
3
Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)?在腹腔内加压气溶胶化疗(PIPAC)期间接触顺铂/奥沙利铂的职业暴露?
Eur J Surg Oncol. 2018 Nov;44(11):1793-1799. doi: 10.1016/j.ejso.2018.05.020. Epub 2018 May 22.
4
Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy.静电加压腹腔内气溶胶化疗期间工作场所环境污染及顺铂和阿霉素气溶胶职业暴露的评估
Eur J Surg Oncol. 2021 Nov;47(11):2939-2947. doi: 10.1016/j.ejso.2021.05.020. Epub 2021 May 19.
5
Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC).腹腔内压力化疗(PIPAC)后的肾肝毒性。
Ann Surg Oncol. 2013 Jul;20(7):2311-6. doi: 10.1245/s10434-012-2840-2. Epub 2013 Feb 3.
6
Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.腹腔内加压气雾化疗(PIPAC)联合全身化疗的安全性和可行性:一种治疗腹膜癌病的创新方法。
World J Surg Oncol. 2016 Apr 29;14:128. doi: 10.1186/s12957-016-0892-7.
7
[Perioperative safety of intraperitoneal aerosol chemotherapy : Analysis of our first 111 pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures].[腹腔内雾化化疗的围手术期安全性:对我们最初111例加压腹腔内雾化化疗(PIPAC)手术的分析]
Chirurg. 2019 Feb;90(2):137-145. doi: 10.1007/s00104-018-0667-5.
8
Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.铂类化合物在腹腔内加压气溶胶化疗(PIPAC)后发生严重超敏反应:文献首例报告。
Cancer Chemother Pharmacol. 2019 Mar;83(3):425-430. doi: 10.1007/s00280-018-3740-3. Epub 2018 Dec 3.
9
Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.腹腔内压力雾化化疗(PIPAC)前后腹腔转移患者腹水中顺铂和阿霉素浓度及腹膜肿瘤结节浓度。
Eur J Surg Oncol. 2018 Jul;44(7):1112-1117. doi: 10.1016/j.ejso.2018.04.020. Epub 2018 May 4.
10
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video).腹腔内高压气溶胶化疗(PIPAC)治疗不可切除的腹膜癌转移(附有视频)。
J Gastrointest Surg. 2018 Feb;22(2):374-375. doi: 10.1007/s11605-017-3565-0. Epub 2017 Sep 12.

引用本文的文献

1
Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Malignancies with Palliative and Bidirectional Intent.用于具有姑息和双向治疗目的的腹膜恶性肿瘤的腹腔内加压气雾化疗(PIPAC)
Cancers (Basel). 2025 Jun 11;17(12):1938. doi: 10.3390/cancers17121938.
2
Twice as Effective? Pressurized Intra-Thoracic Aerosol Chemotherapy: New Frontiers in Pleural Mesothelioma.效果加倍?胸腔内加压雾化化疗:胸膜间皮瘤的新前沿
Med Sci (Basel). 2025 Jun 2;13(2):72. doi: 10.3390/medsci13020072.
3
Safety and Efficacy of Pressurized Intra-Thoracic Aerosol Chemotherapy in Non-Small Cell Lung Cancer Pleural Carcinomatosis: Preliminary Results of a Pilot Study.

本文引用的文献

1
Description of a novel approach for intraperitoneal drug delivery and the related device.一种新型腹腔内药物输送方法及相关装置的描述。
Surg Endosc. 2012 Jul;26(7):1849-55. doi: 10.1007/s00464-012-2148-0. Epub 2012 May 12.
2
Biological monitoring versus air monitoring strategies in assessing environmental-occupational exposure.在评估环境职业暴露方面的生物监测与空气监测策略
J Environ Monit. 2012 Feb;14(2):348-52. doi: 10.1039/c1em10706b. Epub 2011 Dec 1.
3
Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept.
非小细胞肺癌胸膜转移瘤中加压胸腔内雾化化疗的安全性和有效性:一项初步研究的初步结果
Methods Protoc. 2025 May 14;8(3):51. doi: 10.3390/mps8030051.
4
Patient-specific 3D-tissue slices from peritoneal metastases - An model for individual susceptibility analysis.来自腹膜转移瘤的患者特异性3D组织切片——个体易感性分析的模型
Pleura Peritoneum. 2025 Feb 26;10(1):1-9. doi: 10.1515/pp-2024-0012. eCollection 2025 Mar.
5
Implementation and evaluation of Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) for the treatment of patients with malignant pleural effusion: study protocol for the Danish phase-I PITAC-OPC5 study.胸腔内加压雾化化疗(PITAC)治疗恶性胸腔积液患者的实施与评估:丹麦I期PITAC-OPC5研究方案
Pleura Peritoneum. 2024 Nov 18;9(4):141-148. doi: 10.1515/pp-2024-0014. eCollection 2024 Dec.
6
Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis.腹腔镜超声在腹腔热灌注化疗(PIPAC)指导下治疗不可切除性腹膜转移瘤中的作用
Pleura Peritoneum. 2024 Sep 6;9(3):107-112. doi: 10.1515/pp-2024-0007. eCollection 2024 Sep.
7
Safety of pressurized intraperitoneal aerosolized chemotherapy in biliary cancer patients with peritoneal metastases.胆道癌合并腹膜转移患者行腹腔内加压雾化化疗的安全性。
Future Oncol. 2024;20(33):2521-2531. doi: 10.1080/14796694.2024.2394013. Epub 2024 Sep 12.
8
Effects of HyaRegen gel on tumour proliferation of colorectal peritoneal metastases.HyaRegen 凝胶对结直肠腹膜转移瘤增殖的影响。
PLoS One. 2024 Sep 10;19(9):e0307965. doi: 10.1371/journal.pone.0307965. eCollection 2024.
9
Review on treatment of pleural metastasis and malignant pleural effusion with Pressurized IntraThoracic Aerosol Chemotherapy (PITAC).经胸腔加压雾化化疗(PITAC)治疗胸膜转移和恶性胸腔积液的综述
Pleura Peritoneum. 2024 May 17;9(2):47-53. doi: 10.1515/pp-2023-0048. eCollection 2024 Jun.
10
Airborne and surface contamination after rotational intraperitoneal pressurized aerosol chemotherapy using cisplatin.使用顺铂进行腹腔内旋转加压雾化化疗后的空气传播和表面污染
J Gynecol Oncol. 2025 Jan;36(1):e12. doi: 10.3802/jgo.2025.36.e12. Epub 2024 Jun 5.
Dbait 联合二氧化碳气腹治疗人类腹膜癌病的治疗方法:概念验证。
Surg Endosc. 2012 Mar;26(3):847-52. doi: 10.1007/s00464-011-1964-y. Epub 2011 Nov 1.
4
Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study.雾化吉西他滨治疗肺癌患者的可行性和安全性研究。
J Aerosol Med Pulm Drug Deliv. 2011 Dec;24(6):261-70. doi: 10.1089/jamp.2010.0872. Epub 2011 Jul 27.
5
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.随机试验的8年随访:结直肠癌腹膜转移患者的细胞减灭术及腹腔热灌注化疗与全身化疗的对比
Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.
6
[Peritoneum and laparoscopic environment].[腹膜与腹腔镜环境]
Bull Cancer. 2007 Dec;94(12):1043-51. doi: 10.1684/bdc.2007.0519.
7
Drug resistance and the solid tumor microenvironment.耐药性与实体瘤微环境
J Natl Cancer Inst. 2007 Oct 3;99(19):1441-54. doi: 10.1093/jnci/djm135. Epub 2007 Sep 25.
8
Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs.吸入性阿霉素用于肺转移瘤患者的I期研究。
Clin Cancer Res. 2007 Feb 15;13(4):1246-52. doi: 10.1158/1078-0432.CCR-06-1096.
9
Assessing a system to capture stray aerosol during inhalation of nebulized liposomal cisplatin.评估一种在雾化脂质体顺铂吸入过程中捕获游离气雾剂的系统。
J Aerosol Med. 2006 Fall;19(3):385-91. doi: 10.1089/jam.2006.19.385.
10
Drug penetration in solid tumours.药物在实体瘤中的渗透。
Nat Rev Cancer. 2006 Aug;6(8):583-92. doi: 10.1038/nrc1893.